According to a new market research study titled ‘Mobile Cardiac Telemetry Systems Market - Global Analysis and Forecasts by Technology, and End User. The global mobile cardiac telemetry systems market is expected to reach US$ 1,546.4 Mn in 2027 from US$ 564.8 Mn in 2018. The market is estimated to grow with a CAGR of 12.4 % from 2019-2027. The report highlights the trends prevalent in the global mobile cardiac telemetry systems market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due to due to rising prevalence of cardiovascular diseases, benefits of monitoring patients with mobile cardiac telemetry (MCT), and rising geriatric population.
Cardiovascular diseases (CVDs) are the disorders of the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease and other conditions. CVDs are the leading cause of death across the globe, it affects more people as compared to any other disease. According to the World Health Organization’s Fact sheet on cardiovascular diseases, in 2016, approximately 17.9 million people died from CVDs, which was 31.0% of all the global deaths. Among these approximately 85% were due to heart attack and stroke. Heart attacks and strokes are mainly caused due to fatty deposits that block the blood vessels that prevents blood from flowing to the heart or brain. Strokes are also caused due to bleeding from a blood vessel in the brain or from blood clots. According to the European Cardiovascular Disease Statistics 2017, in Europe, every year cardiovascular disease (CVD) causes 3.9 million deaths and more than 1.8 million deaths in the European Union (EU). Owing to the rising cases of cardiovascular diseases across various countries, the need and demand for the mobile cardiac telemetry systems for the treatment of the CVD is expected to increase in the coming years.
Global mobile cardiac telemetry systems market, based on the technology was segmented into lead based and patch based systems. Lead based segment is anticipated to grow at a CAGR of 12.2% during the forecast period. Mobile Cardiac Telemetry (MCT) is the most advanced technology in ambulatory cardiac monitoring. There are many companies in the market that offer different versions of FDA approved MCT monitors with minor variations among the devices. Lead based mobile cardiac telemetry (MCT) systems are devices that have the lead wire that connects the electrodes to the telemetry unit. LifeWatch is at the forefront of remote cardiac monitoring technologies and services for the detection of Atrial Fibrillation (AFIB), and other heart rhythm disorders. The company also offers specialized monitoring programs for post-AFIB procedures and for patients who have experienced a cryptogenic stroke or TIA
Some of the prominent players operating in mobile cardiac telemetry systems market are, Medtronic, BioTelemetry Inc., Applied Cardiac Systems, Inc, Medicomp Inc, Preventice Services, LLC, The Scottcare Corporation, Medi-Lynx (Subisidiary Of Medicalgorithmics, S.A), Zoll Medical Corporation, Welch Allyn, and Telerhythmics, LLC. The market players are focused towards bringing new and innovative products and services to sustain their position in the market. For instance, in May, 2015, Preventice Solutions launched BodyGuardian with BodyGuardian Remote Patient Monitoring System in the United States. The developments performed by the companies are helping the market to grow in the coming years.
The report segments the global mobile cardiac telemetry systems market as follows:
Global Mobile Cardiac Telemetry Systems Market – By Technology
Global Mobile Cardiac Telemetry Systems Market – By End User
Global Mobile Cardiac Telemetry Systems Market – By Geography
Contact Person: Sameer Joshi
Email Id: email@example.com